Biotech 2050 Podcast
79. Leadership in rare diseases, Srini Ramanathan, SVP, R&D Sciences, Horizon Therapeutics
over 3 years ago
78. Translating lab insights for outcomes to cancer patients, Heike Keilhack, CSO,Ribon Therapeutics
over 3 years ago
77. Battling rare diseases: patients and scientists, Ethan Perlstein, Founder and CEO, Perlara
over 3 years ago
76. Advancing immuno-oncology, Michel Detheux, President and CEO, iTeos Therapeutics
over 3 years ago
75. Innovations in cell therapies via microfluidics, Armon Sharei, CEO and Founder, SQZ Biotech
over 3 years ago
74. Pioneering circular oRNA therapeutics, Thomas Barnes, Chief Executive Officer, Orna Therapeutics
over 3 years ago